Patents by Inventor John Henrik Zetterberg

John Henrik Zetterberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220244276
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 4, 2022
    Applicant: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall
  • Publication number: 20220229074
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Application
    Filed: February 1, 2022
    Publication date: July 21, 2022
    Applicant: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall
  • Publication number: 20220196683
    Abstract: The invention relates to method for typing a sample of an individual suffering from, or is suspected to suffer from, a progressive neurodegenerative disease. The invention further relates to methods for assigning a treatment of the individual, based on said typing.
    Type: Application
    Filed: March 27, 2020
    Publication date: June 23, 2022
    Inventors: Betty Marije TIJMS, Pieter Jelle VISSER, Kaj Ingemar BLENNOW, John Henrik ZETTERBERG, Per Johan GOBOM
  • Patent number: 11275092
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Grant
    Filed: July 25, 2019
    Date of Patent: March 15, 2022
    Assignee: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall
  • Publication number: 20200124620
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Application
    Filed: July 25, 2019
    Publication date: April 23, 2020
    Applicant: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall
  • Patent number: 10393759
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: August 27, 2019
    Assignee: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall
  • Publication number: 20170160292
    Abstract: The present invention, in some embodiments, generally relates to methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury. In some embodiments, the brain injury results from a hypoxic event. In some embodiments, methods are provided for determining a measure of the concentration of tau protein in a patient sample containing or suspected of containing tau protein.
    Type: Application
    Filed: September 19, 2016
    Publication date: June 8, 2017
    Applicant: Quanterix Corporation
    Inventors: David Wilson, John Henrik Zetterberg, Kaj Blennow, Jeffrey D. Randall